Featured Resources
-
Guidance on Implementability
This document provides guidance on the planning, design and conduct and reporting of clinical trials, so that the results from late-phase clinical trials are optimised for implementability.
-
Consumer Involvement and Engagement Toolkit
The Consumer Involvement and Engagement Toolkit provides practical advice for researchers and research organisations wishing to conduct patient-centred clinical trials.
-
COVID-19
We’ve created this area for COVID-19 information relevant to clinical trials. In line with the national guidance and emphasis on the safety and well-being of patients, research participants and their families, and health care professionals, researchers and other staff involved in patient care and research, ACTA strongly supports the continuation of investigator-led trials, where it is safe to do so, and with due consideration to any protocol amendments appropriate for the current COVID-19 pandemic.
Search Resources
General search and filters
Filter by:
Topics
Type of Resource
Results filtered by:
-
Risk Management: Guidance for Clinical Trial Networks
-
Consumer involvement in clinical trials: ethics committee members and research governance personnel training webinar – an overview
-
ACTA comparative effectiveness trials requirements for low risk ethics review
-
Establishing a CTN: A Facilitated Workshop for Clinicians and Researchers ACTA Summit 2020
-
Seven steps for statistical success in clinical trials [Good clinical practice guidelines] Part 1
-
Official Opening of the 2020 ACTA Summit: Minister’s Address
-
Trial safety oversight: Guidance for Clinical Trial Networks
-
Authorship and Publication Policy: Guidance for Clinical Trial Networks
-
Data and Safety Monitoring Boards Webinar Series: Statistical Principles
-
Data and Safety Monitoring Boards Webinar Series: How to plan well and be prepared for the unexpected
-
AAAPC Conference: ACTA Workshop Minutes
-
Statistical Analysis Plan